Taxi and ambulance drivers are less likely than workers in almost any other job to die of Alzheimer's disease.

Deborah Kan, founder of "Being Patient," established the platform after her mother's Alzheimer's diagnosis to bridge critical ...

"Based on your evaluation, I’ve reviewed the memory tests you took, and we believe Alzheimer's disease is causing your symptoms. We'd like to see you back in six months.” As they sat in the parking ...

A new study reveals how hyperphosphorylated tau causes reverse electron transport in mitochondria, driving Alzheimer's ...

A new study presents the first complete T2T marmoset genome, advancing Alzheimer's research and primate genomics.

Milinsky, a 79-year-old Pompano Beach grandfather, was the second person in Florida to enroll in treatment with Kisunla, an ...

One of the hallmarks of Alzheimer's disease is the accumulation of a peptide in the brain known as amyloid beta. A new study ...

The U.S. Food and Drug Administration (FDA) recently approved Leqembi, a drug indicated to treat Alzheimer’s disease in patients with mild cognitive impairment. The FDA granted Leqembi an Accelerated ...

Actinogen Medical Ltd (ASX:ACW, OTC:ATGGF) has outlined the scientific rationale supporting its lead drug candidate Xanamem® ...

Alzheimer’s disease disproportionately affects women. Of the roughly seven million Americans living with the condition, ...

New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of just amyloid.